Household & Personal Products

Investor update: Kenvue’s January 29 merger vote, $0.2075 quarterly dividend, and over 90k institutional shares sold—what this means for shareholders.

Suominen Oyj faces 2025 losses but launches a 3‑year “Full Potential” plan to boost profitability, cut costs, and revitalize its non‑woven business.

Kimberly‑Clark’s Q4 2025 earnings show steady growth and a 54th‑year dividend hike, positioning the consumer staples stock as a reliable income play amid market volatility.

Institutional sell‑offs hit Kenvue, yet a new partnership with Kimberly‑Clark México could offset the dip—discover how the move may reshape its growth prospects.

Upexi’s $36 m in‑kind convertible note fuels its Solana‑driven treasury and SaaS ad tech, boosting data‑powered growth despite volatile stock and low PE/ PB ratios.

Venture Life Group’s sharp share‑price swings, negative earnings and stagnant communication reveal a personal‑care firm in distress—will it recover?

Paranovus Entertainment Technology restores Nasdaq compliance amid volatile stock swings, highlighting challenges and prospects for a consumer‑staples company.

Procter & Gamble reports Q2 sales of $22.21 bn with flat revenue, yet EPS beats expectations. Learn how its pricing power, cost discipline and FY 26 guidance keep the consumer‑staples giant a resilient, dividend‑yielding investment.

Interparfums Inc. sparks investor interest as Harbor Capital’s 15‑share purchase and a Yahoo Finance bull case highlight growing fragrance demand and strong licensing strategy, signaling upside potential for 2026.

Hydration Pharmaceuticals Co Ltd-The